Cypre's blog to discuss the latest movements in science.
Cypre and Charles River announce their strategic partnership to leverage Cypre’s 3D Tumor Model Platform with CRL’s genomically annotated and extensively characterized PDX Tumor Model Compendium.
Partner with Cypre to generate translational insights using our 3D tumor microenvironment organoid platform. From targeting the tumor or stroma, to modulating the immune system, we’re built for collaboration.
